Get the Stockscreener App
98.76
0.26%
-0.05
Ani Pharmaceuticals Inc stock is traded at $98.76, with a volume of 54,143.
It is down -0.26% in the last 24 hours and up +12.67% over the past month.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
See More
Previous Close:
$98.81
Open:
$98.88
24h Volume:
54,143
Relative Volume:
0.12
Market Cap:
$2.15B
Revenue:
$486.82M
Net Income/Loss:
$18.78M
P/E Ratio:
120.44
EPS:
0.82
Net Cash Flow:
$100.45M
1W Performance:
+0.09%
1M Performance:
+12.67%
6M Performance:
+57.71%
1Y Performance:
+75.36%
1-Day Range:
$98.88
$98.97
1-Week Range:
$96.08
$99.50
52-Week Range:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Name
Ani Pharmaceuticals Inc
Sector
Phone
(218) 634-3500
Address
210 MAIN STREET WEST, BAUDETTE, MN
Compare ANIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
98.97 | 2.14B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
147.56 | 64.82B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.14 | 47.56B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.3601 | 43.31B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.91 | 21.67B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
402.33 | 18.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Initiated | H.C. Wainwright | Buy |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Mar-12-25 | Initiated | JP Morgan | Overweight |
| Dec-11-24 | Initiated | Leerink Partners | Outperform |
| Oct-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-15-24 | Initiated | CapitalOne | Overweight |
| Aug-22-23 | Reiterated | H.C. Wainwright | Buy |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Sep-07-22 | Initiated | H.C. Wainwright | Buy |
| Nov-02-21 | Initiated | Truist | Buy |
| May-07-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| May-10-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-16-17 | Reiterated | Canaccord Genuity | Buy |
| Jul-31-17 | Initiated | Canaccord Genuity | Buy |
| Feb-22-17 | Downgrade | ROTH Capital | Buy → Neutral |
| Jun-23-16 | Initiated | Raymond James | Strong Buy |
| May-24-16 | Downgrade | Standpoint Research | Buy → Hold |
| Nov-13-15 | Initiated | Standpoint Research | Buy |
| Sep-28-15 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-05-15 | Reiterated | Oppenheimer | Outperform |
| Aug-04-15 | Reiterated | ROTH Capital | Neutral |
| Jul-31-15 | Reiterated | Oppenheimer | Outperform |
| Jul-15-15 | Reiterated | ROTH Capital | Neutral |
| Jun-23-15 | Reiterated | Oppenheimer | Outperform |
| May-18-15 | Reiterated | ROTH Capital | Neutral |
| May-06-15 | Reiterated | Oppenheimer | Outperform |
| Apr-10-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-26-15 | Reiterated | ROTH Capital | Buy |
| Feb-18-15 | Reiterated | Oppenheimer | Outperform |
View All
Ani Pharmaceuticals Inc Stock (ANIP) Latest News
Great Lakes Advisors LLC Has $4.48 Million Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Woodline Partners LP Purchases Shares of 166,448 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals SVP Cook sells $39k in stock - Investing.com
Guidance Update: Is ANI Pharmaceuticals Inc.’s growth already priced inEarnings Summary Report & Daily Market Momentum Tracking - خودرو بانک
Patterns Watch: Can ANI Pharmaceuticals Inc. generate free cash flowTrade Entry Summary & Reliable Breakout Stock Forecasts - خودرو بانک
Weekly Trades: Can ANI Pharmaceuticals Inc lead its sector in growthJuly 2025 Analyst Calls & Real-Time Volume Analysis - خودرو بانک
ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Millennium Management LLC Trims Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Should ANI Pharmaceuticals’ (ANIP) Ambitious 2025 Revenue Forecast Prompt Action From Investors? - ca.finance.yahoo.com
Comerica Bank Sells 7,280 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Guggenheim Raises ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $114.00 - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Federation des caisses Desjardins du Quebec - MarketBeat
Parkman Healthcare Partners LLC Purchases New Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals stock hits 52-week high at 96.61 USD By Investing.com - Investing.com Canada
ANI Pharmaceuticals, Inc. $ANIP Shares Acquired by Northern Trust Corp - MarketBeat
Transcript : ANI Pharmaceuticals, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 01 - MarketScreener
Is ANI Pharmaceuticals Inc. stock a hidden gemQuarterly Earnings Report & High Conviction Trade Alerts - Lancaster City Council
Ani Pharmaceuticals stock hits 52-week high at 96.61 USD - Investing.com
Is ANI Pharmaceuticals Inc. forming higher highs and higher lowsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - Lancaster City Council
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
ANI Pharmaceuticals at H.C. Wainwright: Driving Growth in Rare Diseases By Investing.com - Investing.com Canada
Earnings Chart Overlay Points to ANI Pharmaceuticals Inc. UpsideJuly 2025 Levels & Free High Return Stock Watch Alerts - beatles.ru
AYAL Capital Advisors Ltd Buys New Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 1-Year HighWhat's Next? - MarketBeat
Can machine learning forecast ANI Pharmaceuticals Inc. recovery2025 Sector Review & Stock Portfolio Risk Control - Newser
Is ANI Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Retail & Weekly Hot Stock Watchlists - خودرو بانک
Is ANI Pharmaceuticals Inc. forming a bottoming baseWeekly Volume Report & Real-Time Volume Analysis Alerts - Newser
8,206 Shares in ANI Pharmaceuticals, Inc. $ANIP Bought by Wellington Management Group LLP - MarketBeat
Published on: 2025-09-05 23:12:27 - خودرو بانک
Is ANI Pharmaceuticals Inc. a strong growth stock2025 Market Sentiment & Smart Investment Allocation Insights - خودرو بانک
What to do if you’re stuck in ANI Pharmaceuticals Inc.July 2025 Gainers & Precise Buy Zone Identification - Newser
Should I set a stop loss on ANI Pharmaceuticals Inc.2025 AllTime Highs & Long-Term Capital Growth Ideas - خودرو بانک
What data driven models say about ANI Pharmaceuticals Inc.’s future - Newser
Is ANI Pharmaceuticals Inc.’s growth already priced in2025 Earnings Impact & Advanced Swing Trade Entry Plans - خودرو بانک
Apis Capital Advisors LLC Makes New $4.35 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
What is ANI Pharmaceuticals Inc.’s book value per share2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
ANI Pharmaceuticals Inc. stock outlook for YEAR2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
Forecasting ANI Pharmaceuticals Inc. price range with options dataWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser
What Fibonacci levels say about ANI Pharmaceuticals Inc. reboundQuarterly Portfolio Report & Free Community Supported Trade Ideas - Newser
Technical signs of recovery in ANI Pharmaceuticals Inc.July 2025 Movers & Daily Oversold Bounce Ideas - Newser
How to monitor ANI Pharmaceuticals Inc. with trend dashboardsMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Leading vs lagging indicators on ANI Pharmaceuticals Inc. performanceMarket Performance Recap & Reliable Price Breakout Alerts - Newser
What technical models suggest about ANI Pharmaceuticals Inc.’s comebackJobs Report & Community Consensus Trade Signals - Newser
Fed Meeting: Is ANI Pharmaceuticals Inc. stock forming a cup and handleCEO Change & Safe Entry Trade Signal Reports - خودرو بانک
Should you hold or exit ANI Pharmaceuticals Inc. nowWall Street Watch & Verified Momentum Stock Watchlist - Newser
Aug Swings: Is ANI Pharmaceuticals Inc.’s growth already priced inLayoff News & Weekly Market Pulse Alerts - خودرو بانک
What machine learning models say about ANI Pharmaceuticals Inc.Portfolio Return Report & Free Reliable Trade Execution Plans - Newser
Using R and stats models for ANI Pharmaceuticals Inc. forecasting2025 Support & Resistance & Safe Entry Zone Tips - Newser
Can trapped investors hope for a rebound in ANI Pharmaceuticals Inc.Market Sentiment Review & Growth Focused Stock Pick Reports - Newser
Walleye Capital LLC Has $2.09 Million Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals Inc Stock (ANIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):